DeepMed Research

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

BNT-164

Generic Name: BNT-164

Overview

No overview information available.

Background

No background information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Safety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in BCG Vaccinated Volunteers

Phase 1

Recruiting

Posted: 2022/09/21

Sponsor:BioNTech SE

Safety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in Healthy Volunteers

Phase 1

Active, not recruiting

Posted: 2022/09/13

Sponsor:BioNTech SE

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

Novel TB Vaccines and AI-Driven Solutions Show Promise in Global Fight Against Tuberculosis

3 months ago

Researchers unveil significant advances in tuberculosis vaccine development, including multi-antigen and mRNA-based platforms, addressing limitations of the century-old BCG vaccine.

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy